Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Jianwu Qin"'
Autor:
Jingzhu Zhao, Junyi Wang, Ruochuan Cheng, Jianwu Qin, Zhilong Ai, Hui Sun, Zhuming Guo, Xiaohua Zhang, Xiangqian Zheng, Ming Gao
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2024)
ObjectiveThis study aimed to evaluate the effectiveness and safety of carbon nanoparticles-guided lymph node dissection during thyroidectomy in patients with papillary thyroid cancer(PTC).MethodsClinical trials consisted of two subgroups: unilateral
Externí odkaz:
https://doaj.org/article/51d03e7a8ea64db381a5ca6648511a53
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Medullary thyroid carcinoma (MTC) is one of the common malignant endocrine tumors, which seriously affects human health. Although surgical resection offers a potentially curative therapeutic option to some MTC patients, most patients do not benefit f
Externí odkaz:
https://doaj.org/article/ea095d602b7a4f1d907297e30c6fe3b1
Publikováno v:
Asian Journal of Surgery, Vol 44, Iss 11, Pp 1357-1362 (2021)
Summary: Purpose: Central lymph node metastasis (CLNM) is common in papillary thyroid carcinoma (PTC). The aim of this study was to compare the cT1a and cT1b stages of PTC and to analyze the predictive factors of ipsilateral central lymph node metast
Externí odkaz:
https://doaj.org/article/314514f212b84f4b99e001da89b33d18
Autor:
Jingzhu Zhao, Yihebali Chi, Chuanxiang Hu, Xiaohong Chen, Minghua Ge, Yuan Zhang, Zhuming Guo, Jun Wang, Jie Chen, Jiewu Zhang, Ying Cheng, Zhendong Li, Hui Liu, Jianwu Qin, Jingqiang Zhu, Ruochuan Cheng, Zhengang Xu, Dapeng Li, Pingzhang Tang, Ming Gao, Xiangqian Zheng
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundMedullary thyroid carcinoma (MTC) is a rare type of thyroid cancer; however, it accounted for 13.4% of the disease-specific mortalities. ALTER01031 (NCT02586350) was a randomised, placebo-controlled phase 2b trial that evaluated the efficac
Externí odkaz:
https://doaj.org/article/71bbb6da655642cd96b735b8d222d403
Autor:
Ming Gao, Minghua Ge, Qinghai Ji, Ruochuan Cheng, Hankui Lu, Haixia Guan, Wei Cui, Li Gao, Zairong Gao, Lin Guo, Zhuming Guo, Tao Huang, Xiaoming Huang, Yansong Lin, Qinjiang Liu, Xin Ni, Jianwu Qin, Li Ren, Zhongyan Shan, Hui Sun, Xudong Wang, Zhengang Xu, Yang Yu, Bin Zhang, Daiwei Zhao, Ying Zheng, Jingqiang Zhu, Xiangqian Zheng, Chinese Association of Thyroid Oncology (CATO), China Anti-Cancer Association
Publikováno v:
Cancer Biology & Medicine, Vol 15, Iss 4, Pp 468-477 (2018)
Externí odkaz:
https://doaj.org/article/4e3690075b3345aba1ce6cd3501ea179
Autor:
Ming Gao, Minghua Ge, Qinghai Ji, Ruochuan Cheng, Hankui Lu, Haixia Guan, Li Gao, Zhuming Guo, Tao Huang, Xiaoming Huang, Xiaoming Li, Yansong Lin, Qinjiang Liu, Xin Ni, Yi Pan, Jianwu Qin, Zhongyan Shan, Hui Sun, Xudong Wang, Zhengang Xu, Yang Yu, Daiwei Zhao, Naisong Zhang, Sheng Zhang, Ying Zheng, Jingqiang Zhu, Dapeng Li, Xiangqian Zheng, Chinese Association of Thyroid Oncology, (CATO), Chinese Anti-Cancer Association
Publikováno v:
Cancer Biology & Medicine, Vol 14, Iss 3, Pp 203-211 (2017)
Externí odkaz:
https://doaj.org/article/8ec842aae62c43c49dfa0db04605431b
Publikováno v:
Asian Journal of Surgery, Vol 43, Iss 9, Pp 959-960 (2020)
Externí odkaz:
https://doaj.org/article/904a0346285c45e78ed7c6a8097f6ea1
Efficacy and safety of pralsetinib in Chinese advanced A£7-mutant medullary thyroid cancer patients.
Autor:
Xiangqian Zheng, Meiyu Fang, Yun Fan, Yuping Sun, Meili Sun, Ankui Yang, Bin Zhang, Qinjiang Liu, Hui Liu, Xiaohong Zhou, Tao Huang, Jianwu Qin, Zhaohui Wang, Mengmeng Qin, Zhenwei Shen, Sheng Yao, Yang, Jason, Yu Wang, Ming Gao
Publikováno v:
Endocrine-Related Cancer; Apr2024, Vol. 31 Issue 4, p1-9, 9p
Publikováno v:
Endocrine. 78:484-490
The purpose of this study was to explore the impact of the lymph node ratio on prognosis in papillary thyroid cancer patients with lymph node metastasis.Data from papillary thyroid cancer patients with positive nodes who were initially treated at our
Publikováno v:
Molecular and Cellular Biochemistry. 478:47-57
Chemotherapy resistance is the main reason for the failure of cancer treatment. The mechanism of drug resistance is complex and diverse. In recent years, the role of glucose metabolism and mitochondrial function in cancer resistance has gathered cons